within 50 hours, a time frame that appears to be promising for emergency use in level 3 NICUs. RESULTS Symptom- and sign-assisted genome analysis (SSAGA) is a new din- icopathological correlation tool that maps the clinical features of 591 well-established, recessive genetic diseases with pediatric p